BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15466129)

  • 1. Flawed attention-deficit/hyperactivity disorder medication comparison.
    Adesman A
    Pediatrics; 2004 Oct; 114(4):1132; author reply 1132-3. PubMed ID: 15466129
    [No Abstract]   [Full Text] [Related]  

  • 2. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2006 Nov; 29(11):415-6. PubMed ID: 17131689
    [No Abstract]   [Full Text] [Related]  

  • 3. Single-dose pharmacokinetics of multilayer-release methylphenidate and immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder.
    Quinn D; Bode T; Reiz JL; Donnelly GA; Darke AC
    J Clin Pharmacol; 2007 Jun; 47(6):760-6. PubMed ID: 17395894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Attention deficit hyperactivity disorder in children].
    Bervoets L
    J Pharm Belg; 2002; 57(2):25-32. PubMed ID: 12053824
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of long-acting OROS methylphenidate on routine driving in young adults with attention-deficit/hyperactivity disorder.
    Cox DJ; Mikami AY; Cox BS; Coleman MT; Mahmood A; Sood A; Moore M; Burket R; Merkel RL
    Arch Pediatr Adolesc Med; 2008 Aug; 162(8):793-4. PubMed ID: 18678816
    [No Abstract]   [Full Text] [Related]  

  • 6. Optimizing ADHD therapy with sustained-release methylphenidate.
    Lawrence JD; Lawrence DB; Carson DS
    Am Fam Physician; 1997 Apr; 55(5):1705-9, 1711-2. PubMed ID: 9105199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder.
    Wilens TE; McBurnett K; Bukstein O; McGough J; Greenhill L; Lerner M; Stein MA; Conners CK; Duby J; Newcorn J; Bailey CE; Kratochvil CJ; Coury D; Casat C; Denisco MJ; Halstead P; Bloom L; Zimmerman BA; Gu J; Cooper KM; Lynch JM
    Arch Pediatr Adolesc Med; 2006 Jan; 160(1):82-90. PubMed ID: 16389216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focalin XR for ADHD.
    Med Lett Drugs Ther; 2009 Mar; 51(1308):22-4. PubMed ID: 19305368
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical inquiries. Is methylphenidate useful for treating adolescents with ADHD?
    Mott TF; Leach L; Johnson L
    J Fam Pract; 2004 Aug; 53(8):659-61. PubMed ID: 15298843
    [No Abstract]   [Full Text] [Related]  

  • 10. [Medical treatments of hyperactive child: about the new pharmaceutical forms of methylphenidate marketed in France].
    Le Heuzey MF; Vergnaud S; Mouren MC
    Arch Pediatr; 2006 Jan; 13(1):100-3. PubMed ID: 16239100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication for children with attention disorders.
    Kash IJ
    Pediatrics; 1997 Jun; 99(6):922-3. PubMed ID: 9164792
    [No Abstract]   [Full Text] [Related]  

  • 12. Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?
    Killeen MR
    J Child Fam Nurs; 2000; 3(1):46-8. PubMed ID: 11022478
    [No Abstract]   [Full Text] [Related]  

  • 13. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder.
    Marcus SC; Wan GJ; Kemner JE; Olfson M
    Arch Pediatr Adolesc Med; 2005 Jun; 159(6):572-8. PubMed ID: 15939858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder.
    Corkum P; Panton R; Ironside S; Macpherson M; Williams T
    J Pediatr Psychol; 2008 May; 33(4):368-79. PubMed ID: 18056144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents: update on new stimulant preparations, atomoxetine, and novel treatments.
    Prince JB
    Child Adolesc Psychiatr Clin N Am; 2006 Jan; 15(1):13-50. PubMed ID: 16321724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Need for bedtime dose of ritalin.
    Rogers WB
    Pediatrics; 1996 Aug; 98(2 Pt 1):314. PubMed ID: 8692642
    [No Abstract]   [Full Text] [Related]  

  • 18. No news is bad news?
    J Psychosoc Nurs Ment Health Serv; 1999 Apr; 37(4):15. PubMed ID: 10218185
    [No Abstract]   [Full Text] [Related]  

  • 19. Sustained-release methylphenidate: new preparations. New pharmaceutical forms: a slight advantage for a small number of children.
    Prescrire Int; 2004 Dec; 13(74):203-6. PubMed ID: 15612099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylphenidate and chromosome damage.
    Jacobson-Kram D; Mattison D; Shelby M; Slikker W; Tice R; Witt K
    Cancer Lett; 2008 Feb; 260(1-2):216-8. PubMed ID: 18055105
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.